-
Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026
70% in vivo editing of human APOC3 in a single administration76% triglyceride reduction after a single dose in murine
Lifestyle Content
Technology
-
Little Sparrows Technologies Receives Innovative Technology Designation from Vizient for bili-hut™ Neonatal Phototherapy
-
Tone P Earns Major-Label Milestone as Nino Paid’s Live Rendition of ‘Shine’ Arrives via Signal / Columbia Records
-
RefillGenie Reports Helping Over 18,000 Patients Since 2023
-
BICOM’s DTMS Turns Optical Fiber Into a 20 km Temperature Sensor
-
Apoorva Launches BillWare, a Unified Invoicing and Payments Platform
Entertainment
-
Joseph Gradante Reflects on Raising $30 Million for Allio Capital
-
A Foothold in the Financial District: Hopper Hopper & Strebe Opens San Francisco Office
-
When Genetics Meets Birth Trauma: Jacob D. Fuchsberg Law Firm Breaks Down Who Decides What Injured a Newborn’s Brain
-
China Oil Painting Gallery Spotlights Four Hand-Painted Reproductions of Classic Masterworks
-
Tri-City Custom Upfitters Wins Diamond in Cambridge Readers’ Choice Awards 2026
Health
-
Rently Secures US$12M Growth Credit Facility from January Capital to Scale Rental Innovation Across Asia and the GCC
-
Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
-
Investor Alert: Robbins LLP Informs Investors of the Tenax Therapeutics, Inc. Class Action Lawsuit
-
Fujifilm Introduces instax mini Evo 2™ Hybrid Instant Camera
-
SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law
